Literature DB >> 16529944

Overexpression and characterization of two human salivary proline rich proteins.

Christine Pascal1, Frédéric Bigey, Robert Ratomahenina, Hélène Boze, Guy Moulin, Pascale Sarni-Manchado.   

Abstract

Proline rich proteins (PRP) are among major human saliva constituents and are known to interact with wine tannins that are involved in astringency. To characterize these interactions, a human salivary proline rich pro-protein, PRB4S, was overexpressed in Pichia pastoris. Six recombinant proteins resulting from maturation in bioreactor were detected by SDS-PAGE analysis between 15 and 45 kDa (apparent molecular weight). Two of them, the 45 and the 15 kDa ones, were isolated from culture supernatant by adsorption and permeation chromatography. They were characterized by N-terminal sequencing and MALDI-TOF analysis after trypsic digestion. The 45 kDa protein is glycosylated while the 15 kDa one was obtained after a furin-like proteolysis. Both of them are similar to human whole saliva PRP resulting from proteolysis of PRB4S pro-protein in Golgi network and known as II-1 and IB-5. Because of their sensitivity to proteolysis or their unusual mobility on SDS-PAGE gel, these recombinant proteins seem to be intrinsically unstructured proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16529944     DOI: 10.1016/j.pep.2006.01.012

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  2 in total

1.  Proline-rich salivary proteins have extended conformations.

Authors:  Hélène Boze; Thérèse Marlin; Dominique Durand; Javier Pérez; Aude Vernhet; Francis Canon; Pascale Sarni-Manchado; Véronique Cheynier; Bernard Cabane
Journal:  Biophys J       Date:  2010-07-21       Impact factor: 4.033

2.  A Novel Quantitative Prediction Approach for Astringency Level of Herbs Based on an Electronic Tongue.

Authors:  Xue Han; Hong Jiang; Dingkun Zhang; Yingying Zhang; Xi Xiong; Jiaojiao Jiao; Runchun Xu; Ming Yang; Li Han; Junzhi Lin
Journal:  Pharmacogn Mag       Date:  2017-07-19       Impact factor: 1.085

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.